Isgd Clinical Trials Summit 2026
A clinical trials summit organized by the International Society of Glomerular Disease.
- Date
- November 13, 2026
- Location
- Galveston, Texas
TL;DR
- The summit starts November 13, 2026, in Galveston, Texas.
- The published audience includes patients, nephrologists, regulators, and industry leaders.
- The program lists speakers from universities, hospitals, and life-sciences organizations.
Who you'll find in the room
Patients
Patients are included in the published audience.
Nephrologists
Nephrologists are included in the published audience.
Regulators
Regulators are included in the published audience.
Industry leaders
Industry leaders are included in the published audience.
Featured speakers
54 listedBrad Rovin
The Ohio State University
Jonathan Barratt
University of Leicester
Liz Lightstone
Imperial College London
Marina Vivarelli
Bambino Gesù Children's Hospital, IRCCS
Shikha Wadhwani
UTMB
Ana Malvar
University of Buenos Aires
Carla Nester
University of Iowa
Daniel Gale
University College London
Heather Reich
University of Toronto, University Health Network
Hiddo Heerspink
University Medical Center Groningen
Katherine Tuttle
Providence Health Care/University of Washington
Kirk Campbell
NKF President, University of Pennsylvania
Laurel Damashek
ISGD
Louise Oni
University of Liverpool, UCL and Great Ormond Street Hospital for Children
Matthias Kretzler
University of Michigan
Meg Jardine
The University of Sydney
Myda Khalid
Indiana University School of Medicine
Patrick Nachman
University of Minnesota
Priya Verghese
Ann & Robert H. Lurie Children's Hospital
Rafael Kramann
RWTH Aachen University Faculty of Medicine
Sean Barbour
The University of British Columbia
Suceena Alexander
Christian Medical College
Vlado Perkovic
UNSW Sydney
Alessia Fornoni
University of Miami
Alexander Duncan
Walden Biosciences
Alice Brown
Purespring Therapeutics
Jonathan Hogan
Cabaletta Bio
Laura Barisoni
Duke University
Laura Mariani
University of Michigan
Nicola Tomas
UKE Hamburg
Timothy Niewold
The Hospital for Special Surgery
Abigail Smith
Northwestern University
Adeera Levin
Providence Health
Alex Mercer
JAMCO Pharma Consulting
Barbara Gillespie
ISGD, University of North Carolina
Brendon Neuen
The George Institute for Global Health
Eloise Salmon
University of Michigan
Lesley Inker
Tufts University School of Medicine
Tom Greene
University of Utah Health
Ali Poyan Mehr
Kaiser Permanente, Bernard J. Tyson School of Medicine
Bill Smoyer
Nationwide Children's Hospital
Brittain Kopittke
University of North Carolina
Jennifer McKenzie
Boehringer Ingelheim
Jiahua Li
Vertex
Josh Tarnoff
NephCure
Jula Inrig
Travere Therapeutics
Jule Pinter
UKE Hamburg
Prabir Roy-Chaudhury
University of North Carolina
Robert Brenner
Vera Therapeutics
Sreedhar Mandayam
UT MD Anderson Cancer Center
Sweta Sinha
iTrials
Sydney Tang
The University of Hong Kong
Tobias B. Huber
UKE Hamburg
Uptal Patel
Biogen
Venue & travel
Venue
Galveston, TexasQuestions people ask
5 answeredThe summit starts November 13, 2026.
The summit is held in Galveston, Texas.
The published audience includes patients, nephrologists, regulators, and industry leaders.
It is most useful for nephrologists, trial investigators and industry clinical development staff working on glomerular disease, since the speaker list is large and mixes academic centres such as Ohio State, Leicester and Imperial College London with companies like Vertex, Biogen and Boehringer Ingelheim. Clinicians outside kidney disease or those wanting general clinical research training would get less, as the focus is a single disease area, though patients and regulators also attend.
Attendees at academic and clinical research meetings usually wear business casual, with pharma staff often a notch smarter.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in